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Abstract
The engagement of patients with their health care providers (HCP) improves patients’ quality of
life (QOL), adherence to antiretroviral therapy, and life satisfaction. Engagement with HCP
includes access to HCP as needed, information sharing, involvement of client in decision making
and self-care activities, respect and support of the HCP for the client’s choices, and management
of client concerns. This study compares country-level differences in patients’ engagement with
HCP and assesses statistical associations relative to adherence rates, self-efficacy, self-esteem,
QOL, and symptom self-reporting by people living with HIV (PLHIV). A convenience sample of
2,182 PLHIV was enrolled in the United States, Canada, Puerto Rico, Namibia, and China. Cross-
sectional data were collected between September 2009 and January 2011. Inclusion criteria were
being at least 18 years of age, diagnosed with HIV, able to provide informed consent, and able to
communicate in the local language with site researchers. In the HCP scale, a low score indicated
greater provider engagement. Country comparisons showed that PLHIV in Namibia had the most
HCP engagement (OR 2.80, p < 0.001) and that PLHIV in China had the least engagement (OR
−7.03, p < 0.0001) compared to the PLHIV in the Western countries. Individuals having better
HCP engagement showed better self-efficacy for adherence (t = −5.22, p < 0.0001), missed fewer
medication doses (t = 1.92, p ≤ 0.05), had lower self-esteem ratings (t = 2.67, p < 0.01), fewer self-
reported symptoms (t = 3.25, p < 0.0001), and better overall QOL physical condition (t = −3.39, p
< 0.001). This study suggests that promoting engagement with the HCP is necessary to facilitate
skills that help PLHIV manage their HIV. To improve ART adherence, HCPs should work on
strategies to enhance self-efficacy and self-esteem, therefore, exhibiting fewer HIV-related
symptoms and missing less medication doses to achieve better QOL.
Keywords
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Introduction
HIV is a chronic disease and quality of life (QOL) is an individual’s satisfaction or
happiness with life in domains he or she considers important, becoming an important issue
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for people living with HIV (PLHIV) [1–4]. Challenges that might influence QOL include
disease progression, medication side effects, stigma, disclosure, anxiety, and depression [5–
9]. The length of time with HIV is also positively associated with QOL [10,11]. With these
challenges, PLHIV usually consult their health care providers for assistance [3,12].
Health care providers (HCPs) play an important role from HIV diagnosis to treatment [13–
15]. Teixeira, Gordon, Camhi & Bakken reported that HIV-positive individuals believe that
HCPs need to fully understand the patient’s current situation, including physical and
psychological status, to enhance clinician-patient engagement and make HCPs more
supportive of patients [16]. Most of the PLHIV study participants (84%) believed that
trusting their primary health care provider (HCP) is very important in the clinician-patient
relationship; this trust can encourage PLHIV to share personal health information with their
HCP [16]. Engagement with HCP is defined as client access to HCP as needed, information
sharing, client involvement in decision making and self-care activities, HCPs respect and
support of client choices, and management of client concerns [17].
Research has shown that senior HIV clinicians provide care to improve medical outcomes
compared to less-experienced providers [18], which affects the QOL of HIV-positive
patients. In Brazil, HIV-positive women receiving care from providers with a preventative
care perspective and trained in reproductive health report a better QOL compared to HIV-
positive women who went to providers lacking reproductive health training and counseling
skills [19]. Similarly, other studies conducted regarding chronic diseases such as
hypertension and diabetes indicated that patient-provider communications, including the
quality of information exchange and verbal understanding from both sides, profoundly
impact patients’ health outcome and satisfaction [20].
Adherence to antiretroviral therapy (ART) is an essential task for HIV-positive populations;
patients who are adherent can avoid medication resistance, slow down the progression of
HIV disease and reduce the occurrence of opportunistic infections and even death [21,22].
Studies have shown that engaged HCP relationships with HIV positive individuals enhance
patients’ QOL that in turn prompts them to adhere to ART, resulting in improved patient life
satisfaction compared with those relationships that are not engaged [17,23, 24].
Self-efficacy the belief in one’s own ability to succeed in specific situations is an important
determinant for disease management [25,26]. Adherence self-efficacy in PLHIV is the
confidence held by an individual in her or his ability to follow treatment recommendations,
including specific HIV care such as initiating and adhering to ART [27]. Studies have shown
that adherence self-efficacy is a key attribute in maintaining optimal medication adherence
[28–30]. Perceived self-efficacy among PLHIV can sustain good ART adherence and self-
care behavior with education from the HCP and other support systems if there are any
challenges. Patients’ with higher self-efficacy and a greater belief in their ability to master
tasks are more likely to perform well by accomplishing tasks, goals, and meeting challenges
[28]. Self-efficacy and self-esteem have been shown to have a high correlation in many
HIV-related research studies [31–33].
Self-esteem is an individual’s set of thoughts and feelings about his or her own worth and
importance [34]. A recent report has shown a strong relationship between self-efficacy and
self-esteem for HIV prevention among Hispanic women [33]. Women who reported lower
self-esteem felt discouraged from seeking help, they felt vulnerable, and were not able to
complete their daily chores [33].
HIV is a disease that profoundly influences the daily lives of PLHIV, therefore, QOL has
been discussed from the onset of the HIV epidemic. Physiological and psychosocial aspects
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of HIV progression and the side effects of ART can be related to QOL among HIV-infected
populations [35–37]. With an engaged HCP relationship and good ART adherence, we
assumed, PLHIV should have enhanced QOL. However, we could not find any reports
related to these variables in international populations, we compare PLHIV among Western
countries, China and Namibia. The purpose of our multi-site international study was to
examine the relationship of ART adherence, adherence self-efficacy, self-esteem, and
health-related QOL with patients’ engagement with their HIV HCP. Specifically, we
investigated whether regulatory factors adherence self-efficacy, self-esteem, and medication
adherence were associated with QOL (measured by participants’ capability in participating
in activities), health outcomes, and engagement with HCP. We also looked at whether this
differs by international site.
Methods
Research design
This study is a part of a multi-national and multi-site cross-sectional study that examined
QOL, engagement with HCP, and the strength of association among other variables such as
adherence self-efficacy, self-esteem, and ART adherence.
Sample—A convenience sample of 2,182 PLHIV was enrolled from HIV clinics and
service organizations globally. Participants were recruited from 15 sites throughout the
United States (Boston, Massachusetts, 2 sites; Chicago, Illinois; Cleveland, Ohio; Corpus
Christi, Texas; Durham, North Carolina; Arlington, Texas; Newark, New Jersey; New York
City, New York; San Francisco, California, 3 sites; Seattle, Washington, 2 sites; and
Wilmington, North Carolina). Five other countries/territories had one site each (Canada,
Puerto Rico, Namibia, China, and Thailand). Thailand was the only site that used partial
questionnaires; therefore, their data were not included in our calculation of sites. Cross-
sectional data were collected between September 2009 and January 2011. Inclusion criteria
in this project were being at least 18 years of age, diagnosed with HIV, able to provide
informed consent and able to communicate in the local language with site researchers.
Protection of human subjects
Each study site obtained individual institutional review board (IRB) approval before the
study was conducted. Informed consent was secured from each study participant before
enrollment in the study. The University of California at San Francisco (UCSF) functioned as
the primary site for merging all the study data. UCSF IRB approval also included agreement
for data sharing with all 20 sites and for keeping all data in the central data warehouse at the
UCSF site. Code numbers were assigned and used to protect the confidentiality of all
research participants.
Translation
At four of the participating sites, the instruments were translated from English to the local
language(s): Shanghai, China (Chinese), Bangkok, Thailand (Thai), San Juan, Puerto Rico
(Spanish), and Windhoek, Namibia (Afrikaans and Oshiwambo). Each site followed
established translation procedures. In Shanghai, bilingual investigators translated all of the
agreed-upon instruments into Mandarin and back-translated into English to establish
conceptual equivalence. In Bangkok, the instruments were translated into Thai by three
translators. This translation was validated by three researchers and reviewed by two experts.
In San Juan, one doctoral prepared translator translated the instruments from English to
Spanish. An independent, bilingual translator translated that version of the instruments back
to English; two additional experts reviewed both versions for conceptual and semantic
equivalence. Finally, reliability of the translated instruments was assessed on 20
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participants. In Windhoek, bilingual investigators translated the instruments into both
Afrikaans and Oshiwambo, and back-translated into English to establish conceptual
equivalence.
Instrumentation
Demographic questionnaire—Our demographic survey included 20 items asking age,
gender, ethnicity, education, adequacy of income, current CD4 count, viral load, length of
HIV diagnosis, other health conditions, and HIV disease information with possible HIV
transmission route.
Engagement with Health Care Providers (HCP)—The HCP scale is a 13-item scale
in which clients rate the nature of their interactions with their health care providers on a
four-point scale (1 = always true and 4 = never); a low score indicated greater provider
engagement. The scale was submitted to principal components factor analysis with Varimax
rotation. A one-factor solution emerged with an Eigen value of 8.6 and explained 66.5% of
the variance. Cronbach’s alpha reliability estimate was 0.96 [17].
HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)—Adherence self-
efficacy confidence in one’s ability to comply with a treatment plan has been consistently
linked to adherence over time. The HIV-ASES scale, developed at UCSF, assesses patient
confidence to carry out health-related behaviors (asking physician questions, keeping
appointments, adhering to medication regimen) (Cronbach’s alpha = 0.92). This measure
includes two subscales (Persistence and Integration), has been found to be associated with
adherence to ART in our previous research publication [38].
Rosenberg self-esteem scale—We used this scale to measure self-esteem. It consists
of 10 statements related to overall feelings of self-worth or self-acceptance. The items are
answered on a four-point scale [34]. There is one total score, with a total range from 10 (low
self-esteem) to 40 (high self-esteem). The observed Cronbach’s alpha reliability coefficient
for the total score was 0.59.
HIV medication adherence—The 16 questions consisted of the following instruments:
(a) a list of current ARV medications and questions to record the patients’ history of taking
or stopping antiretroviral medications. This 5-item instrument recorded their current ARV
medications and reasons for stopping ARV medications in the past. (b) AIDS Clinical Trial
Group (ACTG) medications, including a 9-item survey measuring reasons for missed
medications. Items are rated on a 4-point Likert scale (1 = never, 2 = rarely, 3 = sometimes,
and 4 = often). The higher the score means less adherence to their ART medications [14,39];
(c) 3-day recall: This one-item visual analog scale, based on 30-day adherence assessment
[40], accesses 3-day adherence, reporting separately for each drug along a continuum of
“none of my doses” to “every one of my doses.” (d) 30-day recall: This one-item visual
analog scale [40] assesses 30-day adherence, reporting separately for each drug, along a
continuum of “none of my doses” to “every one of my doses.” This scale has been shown to
correlate with other adherence measures such as MEMS caps (Medication Event Monitoring
System, Aprex Corp., Fremont, Calif.). We used an ACTG subscale to calculate the
participants’ adherence.
Quality of life—QOL was measured with Veterans Short Form (VSF)-12 Quality of Life.
We used the physical domains as the variable to measure whether the study participants
were capable of participating in activities as they wanted to [41–43]. VSF-12 is a 12-item
health questionnaire developed from the U.S. Veterans Health Study spanning physical to
psychological domains. The VSF-12 questionnaires have been administered nationally by
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the Veterans Administration (VA) where there have been more than 2.5 million
administrations since 1996. The VSF-12 has undergone extensive testing and was shown to
be reliable and valid in ambulatory care patient populations [44].
Data management
Each site was responsible for its own data collection, ensuring completeness of the survey,
entering, cleaning, and securing the data. After these tasks were completed for all
participants at each site, the data were de-identified and sent to the coordinating center at the
UCSF School of Nursing, Department of Community Health Systems. Once received, the
data were cleaned and aggregated in SPSS 19, instrument sub-factor and total scores were
calculated, and the final data file was sent to each site director for analysis. The analysis
plan was collaboratively developed in October 2010 in Newark, New Jersey, USA, with all
the site principal investigators.
Data analysis
Data analyses included descriptive statistics, t-tests, odds ratios, and ANOVAs. All tests
were conducted using IBM SPSS 19 and Amos19 statistical packages.
Results
The total sample (N = 2182) was composed of 28.6% (n = 625) women (at birth) and 70.3%
(n = 1,534) men (at birth) and 2.4% (n = 52) transgendered and gender queer individuals, of
whom 36.8% (n = 757) were African/African-American, 21.4% (n = 441) white, 20.2% (n =
415) Hispanic, 16.1% (n = 330) Asian/ Pacific Islander, and 3.1% (n = 64) Native American.
Participants mean age was 45.1 years (+/−1.36) with the youngest group from China (M =
37.6, SD = 9.7) and the oldest group from Canada (M = 47.1, SD = 8.2, p < 0.001) More
than a quarter (27.8%, n = 601) of the study participants had achieved an 11th grade
education or less; 37.2% (n = 804) had graduated from high school and 35.1% (n = 759) had
graduated from a two-year college or college/university with a bachelor’s, master’s or
doctoral/medical/law degree. Although the sample as a whole was almost evenly divided- as
those with or without children- the sample from Canada was more likely not to have
children (64.8%, n = 57) and the sample from Namibia was more likely to have children
(90.2%, n = 92). A more detailed demographic analysis has been reported in other papers
[42,45].
Self-efficacy and self-esteem were correlated (r= 0.28, P < 0.0001). Country comparisons
showed that PLHIV in Namibia have the most HCP engagement (OR 2.80, p < 0.001) and
that PLHIV in China have the least engagement with HCP (OR −7.03, p < 0.0001) (Table
1). For the HCP scale, a low score indicated greater provider engagement. Individuals
having better HCP engagement showed better adherence self-efficacy (t = −5.22, p <
0.0001), missed fewer medication doses (t = 1.92, p = 0.05), had lower self-esteem (t = 2.67,
p < 0.01), reported fewer symptoms (t = 3.25, p < 0.0001), and better overall QOL physical
condition (t = −3.39, p < 0.001) Table 2.
Discussion
Sandelowski et al. reported that engagement with the provider facilitated better ART
adherence [43,46–48]. The engagement between HCPs and patients can influence whether
patients take medication on time and whether they miss doses [17,49], the engaged
relationship is important for both the HCPs and patients. In addition, there are power
struggles between HCPs and patients because patients are seeking care from their HCP [50].
Chen et al. Page 6
J AIDS Clin Res. Author manuscript; available in PMC 2014 February 24.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Maintaining good engagements between HCPs and patients are one of the learning
techniques that improve relationships and can enhance health outcomes.
In this study, physicians were the primary HCP for participants in China and Namibia. That
was because the role of the nurse practitioners and physician assistants are non- existent in
these countries. In the Western countries, the majority of the study participants’ HCPs were
nurse practitioners and physician assistants. Therefore, it is difficult to compare whether
nurse practitioners or physician assistants engaged more with PLHIV compared to
physicians who provided care to the study participants in China and Namibia.
Participants in this study from Namibia had the highest engagement with their HCP, fewer
self-reported missed medication doses, fewer self-reported symptoms, and better overall
QOL compared to the rest of the study participants. One might be able to explain that these
study participants believe they could take care of themselves by having higher self-efficacy
with good self-esteem while relying on the encouragement and support from their HCPs. In
addition, Namibia has a less technology driven healthcare system and patients and providers
might have more face time with each other. They might also feel culturally supported. Thus,
it could be that those patients that experienced physical symptoms and ART side effects
reported them to their HCP sooner creating an environment for healthcare problems to be
managed earlier. In contrast, Chinese study participants reported less engagement with their
HCP, less adherence self-efficacy, and lower self-esteem. Living in an authoritarian
environment, such as China, PLHIV might have less opportunity for negotiation with HCPs.
This report supports other studies conducted in China; the stigma of HIV is so severe that
HCPs sometimes discriminate against PLHIV [15,48,51–53].
Adherence to antiretroviral therapy is the key to maintaining viral suppression [54,55].
Adherence has also been associated with better quality of life, general health, daily function,
social performance, mental health, and higher CD4 counts [28,56]. Factors found to be
associated with non-adherence behaviors include the following HIV-related phenomena:
forgetting to take pills, having insufficient HIV knowledge, having a higher viral load, using
alcohol, sleeping through the dose, being away from home, having a change in routine,
being busy, being too sick to take the pills, not being able to tolerate the side effects of the
ART, or being depressed [57–59]. In this study, participants who engaged more with their
HCP presented with higher adherence rates compared to those who had less engagement
with their HCP.
In this study, adherence self-efficacy and self-esteem were correlated; it seems that these
study participants were confident in keeping up with their medication adherence. They
might need encouragement from their HCP to maintain the medication adherence self-
efficacy. Not surprisingly, those patients’ who were engaged with their HCP missed fewer
medications and had fewer self-reported symptoms. One might hypothesize that people who
value engagement with their HCP remind themselves to take medications on time and have
good ART adherence self-efficacy
Better engagements between HCPs and patients facilitate health information exchange on
both sides. Perhaps the trust between HCPs and PLHIV leads to better engagements.
Efficient communication between HCPs and patients is highly related to the best patient care
decisions; if appropriate, family members should be included in the patients’ care plan. In a
trustful engagement, patients can give information that makes it possible for HCPs to better
understand the patients and to optimize the patients’ living conditions (for example, by
modifying patient HIV management). The engagement between HCPs and patients seems to
have an important impact on the major outcomes in HIV care ART adherence and QOL. Our
study supports other studies showing that engagement with HCP plays a vital role in
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influencing the QOL of PLHIV [18,29,60]. Future studies should focus on the relative
impact of these factors on disease management and HIV care, and on the extent to which
enhancement of the engagement between HCPs and HIV-infected patients may advance
patient QOL.
Limitations
There are several limitations in this multi-national and multi-site cross-sectional study. First,
many study participants were recruited from Western countries (Canada, United States, and
Puerto Rico). Other participants were recruited from China, and Namibia. Therefore, the
participants from Western countries were heavy weighted. Second, governmental policies
and funding for providing care vary from country to country. In China, few HCPs are trained
to provide HIV-related care [61]. Therefore, patients in China might not have been able to
select the HCP in which they could engage with the best. Alternative methods to strengthen
their adherence self-efficacy may have been utilized, such as peer support groups or nurses
that are not considered to be their HCP. In addition, HIV ART selections were limited due to
availability and funding [62]. Third, people willing to pay for imported ART out of pocket
with less side effects, may have a higher rate of adherence to the ART in comparison to
people who relied on the government assigned ART which might cause unpleasant side
effects [62,63]. Fourth, this study did not differentiate whether participants who used ART
longer have higher adherence self-efficacy and self-esteem compared to participants who
used ART for shorter periods. ART naïve participants might engage better with HCP, but
show less self-efficacy for adherence. Therefore, future studies should recruit both ART
naïve and experienced participants to examine whether self-efficacy changed according to
length of time using ART. Finally, the data analysis of this study did not include mental
health (e.g., stress or anxiety), which might be a factor in changing the engagement with
HCP, adherence behavior, and decreasing overall QOL.
Conclusions
This study suggests that promoting engagement with the HCP is necessary to facilitate skills
that help PLHIV-manage their HIV. To enhance ART adherence in PLHIV, HCPs should
work on strategies to improve self-efficacy and self-esteem, therefore, decreasing HIV-
related symptoms and missing less medication doses to achieve better QOL in the PLHIV
population. Tailored interventions to strength the HCP-PLHIV engagement should be
designed and tested. Future studies should evaluate whether the interventions focusing on
enhancing self-efficacy and self-esteem can be translated to other cultures.
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